Croda International Plc with ticker (LON:CRDA) now has a potential downside of -11.6% according to JP Morgan.
JP Morgan set a target price of 6,200 GBX for the company, which when compared to the Croda International Plc share price of 6,920 GBX at opening today (27/01/2023) indicates a potential downside of -11.6%. Trading has ranged between 5,862 (52 week low) and 8,214 (52 week high) with an average of 285,391 shares exchanging hands daily. The market capitalisation at the time of writing is £9,662,769,680.
Croda International PLC is a United Kingdom-based consumer care and life sciences focused company. The Company operates through two segments: Consumer Care, and Life Sciences. The Consumer Care segment is focused on high-value niches in the markets of skin care, hair care, solar protection, fabric and surface care, and fragrances. The Consumer Care comprises four businesses: beauty care, beauty actives, home care, and fragrances and flavors. The Company’s Life Sciences segment comprises three businesses, including patient health, consumer and veterinary health, crop protection, and seed enhancement. It is engaged in leveraging in-house developed and acquired technologies, building scale for the delivery of customers’ drug, vaccine, and crop science products.
Croda International Plc -11.6% potential downside indicated by JP Morgan
[shareaholic app="share_buttons" id_name="post_below_content"]
- Written by: Charlotte Edwards
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Croda International Plc's Q3 2024 sales rose to £407m, up 5% year-on-year. Despite currency challenges, full-year profit outlook remains steady.
Croda International Plc appoints Stephen Oxley as Chief Financial Officer, bringing his extensive experience from Johnson Matthey and nearly 30 years at KPMG.
Croda International Plc (LON:CRDA) appoints Ian Bull as Non-Executive Director effective 25 June 2024, bringing vast financial and board experience.
